Open AccessSeverity of hypoglycaemia and health‐related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe
Author(s) -
Pawaskar Manjiri,
Witt Edward A.,
Engel Samuel S.,
Rajpathak Swapnil N.,
Iglay Kristy
Publication year - 2018
Publication title -
endocrinology, diabetes and metabolism
Language(s) - English
Resource type - Journals
ISSN - 2398-9238
DOI - 10.1002/edm2.11
Subject(s) - productivity , work productivity , health care , work (physics) , quality of life (healthcare) , type 2 diabetes , medicine , quality (philosophy) , diabetes mellitus , nursing , economics , economic growth , endocrinology , engineering , mechanical engineering , philosophy , epistemology
Summary Aims Hypoglycaemia in patients with type 2 diabetes mellitus (T2 DM ) is associated with poor health outcomes, such as reduced health‐related quality of life ( HRQ oL). This study aimed to assess the impact of hypoglycaemic events by severity on HRQ oL, work productivity and healthcare costs in patients with T2 DM . Materials and Methods European patients with T2 DM selected from the National Health and Wellness Survey who were currently receiving pharmacologic therapy were stratified into 3 groups based on the reported history and severity of hypoglycaemic events (no event, nonsevere, severe) experienced in the previous 3 months. Patients’ work productivity, HRQ oL, healthcare resource use ( HCRU ) and associated costs were assessed as self‐reported outcomes. Results Of 1269 patients included in the study, 652 (51.4%) patients had not experienced an event, while 533 (42.0%) and 84 (6.6%) patients had experienced nonsevere and severe hypoglycaemic events, respectively, in the previous 3 months. An increase in hypoglycaemia severity was associated with a decrease in HRQ oL, and an increase in HCRU and healthcare costs. Conclusions The impact of hypoglycaemia varies by severity and has a negative impact on HRQ oL and overall HCRU and costs.